Comparison of the Accuracy and Reliability of AMH, FSH and AFC in Predicting Ovarian Response (AMH FSH AFC)

June 23, 2014 updated by: Manh Tuong Ho, Vietnam National University
Serum bio-markers have different prediction values for ovarian response during ovarian stimulation in-vitro fertilization

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

820

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Ho Chi Minh
      • Ho Chi Minh City, Ho Chi Minh, Vietnam
        • An Sinh Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Age ≤ 45 years at the time of FSH starting
  • BMI < 25 kg/m2,
  • First IVF attempt
  • Receiving GnRH-antagonist protocol
  • Had oocyte retrieval

Exclusion Criteria:

  • Had ovarian stimulation or ovulation induction within 2 months prior to the study
  • PCOS
  • Had ovarian tumor or endometrioma
  • Hyperprolactinemia
  • Thyroid hormone disorders
  • Pituitary failure
  • Had other medical situations such as liver failure, renal failure, heart disease, diabetes, depression
  • Had IVM

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Number of oocytes
Time Frame: At the time of oocyte retrieval
At the time of oocyte retrieval
number of oocytes at time of oocyte retrieval
Time Frame: up to 14 days
up to 14 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2013

Primary Completion (Actual)

October 1, 2013

Study Registration Dates

First Submitted

June 23, 2014

First Submitted That Met QC Criteria

June 23, 2014

First Posted (Estimate)

June 25, 2014

Study Record Updates

Last Update Posted (Estimate)

June 25, 2014

Last Update Submitted That Met QC Criteria

June 23, 2014

Last Verified

June 1, 2014

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 1234-DHYD

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Infertility

Clinical Trials on Blood test

3
Subscribe